Mesalamine 4 g Sachet for the Induction of Remission in Active, Mild to Moderate Ulcerative Colitis (UC)
Status:
Completed
Trial end date:
2018-04-03
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to investigate the efficacy of mesalamine for the induction of
clinical and endoscopic remission in subjects with active, mild to moderate UC. Subject will
receive 4 g extended release granules (sachet) once daily.